Medicus Pharma (MDCX) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
China SXT Pharmaceuticals is the larger company by market cap ($246,708 vs $140,466), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDCX | SXTC |
|---|---|---|
| Share price | $0.0937 | $0.1867 |
| Market cap | $140.47K | $246.71K |
| 1-day change | -8.04% | -45.67% |
| YTD return | -93.34% | — |
| 1-year return | -95.86% | — |
| EPS (TTM) | $-119.00 | $-730.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $139.00 | $83,760.00 |
| 52-week low | $0.084 | $0.1703 |
| Distance from 52-week high | -99.93% | -100.00% |
| Analyst consensus | none | — |
| Avg. price target upside | +4702.56% | — |
| Average volume | 92.96K | 4.71M |
| Shares outstanding | 1.50M | 1.32M |
| Employees | 16 | 56 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
About China SXT Pharmaceuticals
SXTC stock →China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Health Care · Biotechnology: Pharmaceutical Preparations · 56 employees
MDCX vs SXTC FAQ
Which is bigger, Medicus Pharma or China SXT Pharmaceuticals?
China SXT Pharmaceuticals (SXTC) is larger, with a market capitalization of $246.71K compared with $140.47K for Medicus Pharma (MDCX).
Are Medicus Pharma and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.